Poland transposes EU Braille format requirements for drug packaging
This article was originally published in SRA
Executive Summary
As of 1 November 2008, marketing authorisation holders in Poland will be required to use the Braille format on human drugs packaging. The Polish ministry of health has already started a consultation process on the draft decree introducing the change, which is a result of amendments made in the EU pharmaceutical legislation in 2004. Recently, the ministry also issued a separate decree concerning the labeling of veterinary medicines. To date, packaging requirements for human and veterinary drugs have been regulated in one decree, which was adopted in 2002.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.